| abstract |
The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and compounds containing them pharmaceutical composition. The present invention also relates to the preparation of novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them and their Methods of novel intermediates involved in the synthesis. Compounds of formula (I) are useful as PARP-1 inhibitors in the treatment of eg cancer. |